The Native Antigen Company Expands Into New Facilities
Dr Nick Roesen, CSO, The Native Antigen Company
The Native Antigen Company has announced that it has relocated into larger facilities, in Oxfordshire, UK. The new building has purpose-built laboratories and doubles the company’s manufacturing capacity. This will increase the speed of new product development within NAC’s core business of infectious disease antigens and antibodies. The new laboratory space also enables NAC to add custom immunoassays to its offering to support customer’s ELISA assay and lateral flow device requirements.
The new suite of laboratories has been established to satisfy increasing commercial demands and accommodate NAC’s growing R&D pipeline. The move facilitates the expansion of the Company’s custom services for recombinant protein production, based on its proprietary mammalian cell expression system. The HEK293 expression system used at NAC has been used to prepare a wide range of complex recombinant proteins, that have been shown to be glycosylated and to demonstrate functional activity.
Dr Nick Roesen, Chief Scientific Officer, NAC, said: “I am delighted with the new facilities and the increased capacity that they provide. The addition of immunoassay development services will enable our customers to work with us from protein expression through to development of an immunoassay for a specific protein. In providing this new service we aim to fill the gap between small-scale R&D expression and high-end pharmaceutical scale GMP manufacturing. We are excited to offer this to our customers, while at the same time progressing our own new product pipeline for infectious disease antigens and anitbodies.”
This article has been republished from materials provided by The Native Antigen Company. Note: material may have been edited for length and content. For further information, please contact the cited source.
Antitumor Immune Function in Liver Controlled by Gut MicrobiomeNews
Scientists have found a connection between bacteria in the gut and antitumor immune responses in the liver. The study showed that bacteria found in the gut of mice affect the liver’s antitumor immune function. The findings have implications for understanding the mechanisms that lead to liver cancer and for therapeutic approaches to treat them.READ MORE
You Are What Your Mother EatsNews
While many factors, such as the age of the mother, overall health and genetics ultimately play a role, the correlation between a mother’s nutrition habits and metabolism has been proved to directly impact the growth of her child. And researchers believe they may be one step closer to knowing why.READ MORE
Immune Cells Form Clots in Tumors Aiding Lung Cancer's SpreadNews
Researchers have found that by helping to form clots within tumors, immune cells that flock to a particular type of lung cancer are actually building a foundation for the tumor to spread within the body.READ MORE
Comments | 0 ADD COMMENT
2nd Annual Artificial Intelligence in Drug Development Congress
Sep 20 - Sep 21, 2018